A clinical trial is investigating the potential of high doses of vitamin B3, or niacin, to improve outcomes for glioblastoma patients. Researchers discovered that niacin might reactivate immune cells suppressed by tumors, enhancing their ability to combat the cancer. Early findings indicate that patients are experiencing improved progression-free survival rates.
A Common Vitamin Could Help Fight Deadly Brain Cancer
Vitamin B3 Shows Promise in Glioblastoma Trials
Seoul Globe Desk
Editorial Team
Published on June 22, 2026
1 min read
